Sequoia Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Sell |
3,340
-344
| -9% | -$43.5K | ﹤0.01% | 1078 |
|
|
2025
Q1 | $471K | Buy |
3,684
+479
| +15% | +$61.3K | ﹤0.01% | 868 |
|
|
2024
Q4 | $424K | Buy |
3,205
+597
| +23% | +$78.9K | ﹤0.01% | 865 |
|
|
2024
Q3 | $380K | Buy |
2,608
+199
| +8% | +$29K | ﹤0.01% | 860 |
|
|
2024
Q2 | $331K | Hold |
2,409
| – | – | ﹤0.01% | 844 |
|
|
2024
Q1 | $331K | Buy |
2,409
+349
| +17% | +$47.9K | ﹤0.01% | 819 |
|
|
2023
Q4 | $280K | Sell |
2,060
-877
| -30% | -$119K | ﹤0.01% | 957 |
|
|
2023
Q3 | $359K | Sell |
2,937
-113
| -4% | -$13.8K | 0.01% | 615 |
|
|
2023
Q2 | $387K | Sell |
3,050
-870
| -22% | -$110K | 0.01% | 602 |
|
|
2023
Q1 | $506K | Buy |
3,920
+966
| +33% | +$125K | 0.01% | 454 |
|
|
2022
Q4 | $388K | Sell |
2,954
-92
| -3% | -$12.1K | 0.01% | 509 |
|
|
2022
Q3 | $356K | Sell |
3,046
-2,560
| -46% | -$299K | 0.01% | 350 |
|
|
2022
Q2 | $659K | Sell |
5,606
-32
| -0.6% | -$3.76K | 0.02% | 283 |
|
|
2022
Q1 | $735K | Sell |
5,638
-5,958
| -51% | -$777K | 0.02% | 289 |
|
|
2021
Q4 | $1.77M | Buy |
11,596
+10,313
| +804% | +$1.57M | 0.05% | 189 |
|
|
2021
Q3 | $207K | Sell |
1,283
-9,138
| -88% | -$1.47M | 0.02% | 245 |
|
|
2021
Q2 | $1.71M | Buy |
10,421
+954
| +10% | +$156K | 0.06% | 165 |
|
|
2021
Q1 | $1.43M | Buy |
9,467
+1,783
| +23% | +$268K | 0.06% | 158 |
|
|
2020
Q4 | $1.16M | Buy |
7,684
+2,978
| +63% | +$451K | 0.05% | 172 |
|
|
2020
Q3 | $637K | Buy |
4,706
+2,882
| +158% | +$390K | 0.03% | 199 |
|
|
2020
Q2 | $249K | Buy |
+1,824
| New | +$249K | 0.01% | 316 |
|
|
2019
Q2 | – | Sell |
-2,019
| Closed | -$226K | – | 380 |
|
|
2019
Q1 | $226K | Buy |
+2,019
| New | +$226K | 0.02% | 324 |
|
|
2015
Q3 | – | Sell |
-1,791
| Closed | -$220K | – | 186 |
|
|
2015
Q2 | $220K | Buy |
+1,791
| New | +$220K | 0.09% | 171 |
|